The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV
- PMID: 36708497
- DOI: 10.1007/s11904-023-00648-y
The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV
Abstract
Purpose of review: To synthesize recent evidence relating the gut microbiome and microbial metabolites to cardiovascular disease (CVD) in people living with HIV (PLWH).
Recent findings: A few cross-sectional studies have reported on the gut microbiome and cardiovascular outcomes in the context of HIV, with no consistent patterns emerging. The largest such study found that gut Fusobacterium was associated with carotid artery plaque. More studies have evaluated microbial metabolite trimethylamine N-oxide with CVD risk in PLWH, but results were inconsistent, with recent prospective analyses showing null effects. Studies of other microbial metabolites are scarce. Microbial translocation biomarkers (e.g., lipopolysaccharide binding protein) have been related to incident CVD in PLWH. Microbial translocation may increase CVD risk in PLWH, but there is insufficient and/or inconsistent evidence regarding specific microbial species and microbial metabolites associated with cardiovascular outcomes in PLWH. Further research is needed in large prospective studies integrating the gut microbiome, microbial translocation, and microbial metabolites with cardiovascular outcomes in PLWH.
Keywords: Cardiovascular disease; Gut microbiome; HIV; Metabolome.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Gut microbiome and cardiometabolic comorbidities in people living with HIV.Microbiome. 2024 Jun 14;12(1):106. doi: 10.1186/s40168-024-01815-y. Microbiome. 2024. PMID: 38877521 Free PMC article. Review.
-
The human microbiome and gut-liver axis in people living with HIV.Curr HIV/AIDS Rep. 2023 Jun;20(3):170-180. doi: 10.1007/s11904-023-00657-x. Epub 2023 May 2. Curr HIV/AIDS Rep. 2023. PMID: 37129834 Free PMC article. Review.
-
Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection.Microbiome. 2023 May 27;11(1):119. doi: 10.1186/s40168-023-01566-2. Microbiome. 2023. PMID: 37237391 Free PMC article.
-
Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis.Front Immunol. 2021 Apr 15;12:664371. doi: 10.3389/fimmu.2021.664371. eCollection 2021. Front Immunol. 2021. PMID: 33936102 Free PMC article.
-
Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected Adults.J Am Heart Assoc. 2019 May 7;8(9):e011037. doi: 10.1161/JAHA.118.011037. J Am Heart Assoc. 2019. PMID: 31030595 Free PMC article.
Cited by
-
Distinct fecal microbial signatures are linked to sex and chronic immune activation in pediatric HIV infection.Front Immunol. 2023 Aug 29;14:1244473. doi: 10.3389/fimmu.2023.1244473. eCollection 2023. Front Immunol. 2023. PMID: 37711620 Free PMC article.
-
Exercise to Prevent Accelerated Vascular Aging in People Living With HIV.Circ Res. 2024 May 24;134(11):1607-1635. doi: 10.1161/CIRCRESAHA.124.323975. Epub 2024 May 23. Circ Res. 2024. PMID: 38781293 Free PMC article. Review.
-
Sex Hormones, the Stool Microbiome, and Subclinical Atherosclerosis in Women With and Without HIV.J Clin Endocrinol Metab. 2024 Jan 18;109(2):483-497. doi: 10.1210/clinem/dgad510. J Clin Endocrinol Metab. 2024. PMID: 37643897 Free PMC article.
-
Role of the Gut Bacteria-Derived Metabolite Phenylacetylglutamine in Health and Diseases.ACS Omega. 2024 Jan 8;9(3):3164-3172. doi: 10.1021/acsomega.3c08184. eCollection 2024 Jan 23. ACS Omega. 2024. PMID: 38284070 Free PMC article. Review.
-
The NLRP3 inflammasome and gut dysbiosis as a putative link between HIV-1 infection and ischemic stroke.Trends Neurosci. 2023 Aug;46(8):682-693. doi: 10.1016/j.tins.2023.05.009. Epub 2023 Jun 15. Trends Neurosci. 2023. PMID: 37330380 Free PMC article. Review.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Trickey A, May MT, Vehreschild J-J, Obel N, Gill MJ, Crane HM, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. The Lancet HIV. 2017;4(8):e349–56. https://doi.org/10.1016/S2352-3018(17)30066-8 . - DOI
-
- Rasmussen LD, May MT, Kronborg G, Larsen CS, Pedersen C, Gerstoft J, et al. Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study. Lancet HIV. 2015;2(7):e288–98. https://doi.org/10.1016/S2352-3018(15)00077-6 . - DOI - PubMed
-
- de Coninck Z, Hussain-Alkhateeb L, Bratt G, Ekström AM, Gisslén M, Petzold M, et al. Non-AIDS mortality is higher among successfully treated people living with HIV compared with matched HIV-negative control persons: a 15-year follow-up cohort study in Sweden. AIDS Patient Care STDS. 2018;32(8):297–305. https://doi.org/10.1089/apc.2018.0015 . - DOI - PubMed - PMC
-
- Farahani M, Mulinder H, Farahani A, Marlink R. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017;28(7):636–50. https://doi.org/10.1177/0956462416632428 . - DOI - PubMed
-
- Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, et al. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. The Lancet HIV. 2019;6(2):e93–104. https://doi.org/10.1016/S2352-3018(18)30295-9 . - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials